Olema Appoints Jason O'Byrne As CFO

August 13, 2026 — 07:17 am EDT

Written by RTTNews.com for RTTNews

(RTTNews) - Olema Pharmaceuticals Inc. (OLMA), a clinical-stage biopharmaceutical company, on Thursday appointed Jason O'Byrne as Chief Financial Officer.

O'Byrne brings more than two decades of finance and global operations experience joins the company from Vir Biotechnology, Inc. (VIR), served as executive vice president and CFO.

The appointment comes as Olema prepares for pivotal data from its OPERA-01 trial and a potential first commercial launch.

Shane Kovacs departed as Chief Operating and Financial Officer on January 30, with CEO Sean Bohen serving as interim Principal Financial Officer until Jason O'Byrne was appointed CFO.

In the pre-market trading, Olema Pharmaceuticals is 1.15% lesser at $10.32 on the Nasdaq.

In the pre-market trading, Vir Biotechnology is 0.89% higher at $9.04 on the Nasdaq.

RTTNews

Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Olema Appoints Jason O'Byrne As CFO

Tags

Latest Articles